Publications

Aldiri, I., Ajioka, I., Beisi, X., Zhang, J., Chen, X., Benavente, C., Finkelstein, D., Johnson, D., Akiyama, J., Pennacchio, L., Dyer, M.A. (2015) Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development, 142(23):4092-106.

Benavente, C. A., Dyer, M. A. (2015). Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma. In Methods in Molecular Biology. (pp. 307-17). New York: Springer Science+Business Media.

Benavente, C. A., Dyer, M. A. (2015). Genetics and Epigenetics of Human Retinoblastoma. Annual Reviews of Pathology: Mechanisms of Disease,(10), 547-562.

Steward, E., Goshorn, R., Bradley, C., Griffiths, L. M., Benavente, C., Twarog, N. R., Caufield, W, Freeman, B. B. 3rd, Bahrami, A., Pappo, A., Wu, J., Loh, A., Karlström, Å., Calabrese, C., Gordon, B., Tsurkan, L., Hatfield, M.J., Potter, P.M., Snyder, S.E., Thiagarajan, S., Shirinifard, A., Sablauer, A., Shelat, A.A., Dyer, M.A. (2014) Targeting the DNA repair pathway in Ewing sarcoma. Cell Reports, 9(3):829-41.

Benavente, C. A., Finkelstein, D., Johnson, D. A., Marine, J. C., Ashery-Padan, R., Dyer, M. A. (2014). Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget, 5(20), 9594-608.

Benavente, C. A., McEvoy, J. D., Finkelstein, D., Wei, L., Kang, G., Wang, Y. D., Neale, G., Ragsdale, S., Valentine, V., Bahrami, A., Temirov, J., Pounds, S., Zhang, J., Dyer, M. A. (2013). Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget, 4(6), 844-59.

Zhang, J.*, Benavente, C. A.*, McEvoy, J.*, Flores-Otero, J.*, Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., Brennan, R., Rusch, M., Manning, A. L., Ma, J., Easton, J., Shurtleff, S., Mullighan, C., Pounds, S., Mukatira, S., Gupta, P., Neale, G., Zhao, D., Lu, C., Fulton, R. S., Fulton, L. L., Hong, X., Dooling, D. J., Ochoa, K., Naeve, C., Dyson, N. J., Mardis, E. R., Bahrami, A., Ellison, D., Wilson, R. K., Downing, J. R., Dyer, M. A. (2012). A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature, 481(7381), 329-34. 0028-0836. *Authors contributed equally to this manuscript. Faculty of 1000 (F1000)

Benavente, C. A., Schnell, S. A., Jacobson, E. L. (2012). Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. PloS ONE, 7(7), e42276.

Bermudez, Y., Benavente, C. A., Meyer, R. G., Coyle, W. R., Jacobson, M. K., Jacobson, E. L. (2011). Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PloS ONE, 6(5), e20487.

Benavente, C. A., Jacobson, M. K., Jacobson, E. L. (2009). NAD in skin: therapeutic approaches for niacin. Current pharmaceutical design, 15(1), 29-38. 1381-6128.

Benavente, C. A., Jacobson, E. L. (2008). Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free radical biology & medicine, 44(4), 527-37. 0891-5849.

Benavente, C. A., Sierralta, W. D., Conget, P. A., Minguell, J. J. (2003). Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth factors, 21(2), 87-94. 0897-7194.